Previous studies identified downregulation of SFTPB in mice to be associated with accelerated tumour growth and rate of epithelial-mesenchymal transition38, and higher SFTPB expression in tumour samples is associated with better survival among lung cancer patients37. The gene discussed is SFTPB; the disease is lung cancer.